US FDA expects more resources to fund biosimilar reviews and plant inspections
Biosimilars will mean more facility inspections and reviews according to the US FDA, which is confident its funding will be increased accordingly.
Archives for March 10, 2015
Merck-NewLink Ebola vaccine trial starts in Guinea
A Phase III trial of Merck & Co.’s Ebola vaccine launched in Guinea last Saturday.